Show an ad over header. AMP

I am the FIRST!!!

Stocks fell over 3% on Wednesday

Stocks took a hit on Wednesday, with the S&P 500, Dow Jones Industrials Average and Nasdaq dropping more than 3% across the board.

Why it matters: The volatility is a break from the stock market grinding higher in the face of spiking coronavirus cases, a stalling economy and gridlocked negotiations over an additional stimulus package.


Background: New lockdowns are being imposed in Europe as nations exceed daily infection records and COVID-19 cases also surge across the United States.

Details: Stock indices in Germany, France and Italy fell over 3% on Wednesday.

  • The S&P 500 fell 3.5%, while the Dow Jones Industrials Average dropped 3.4% (or 940 points). The Nasdaq sunk 3.7%.
  • Oil prices fell more than 5%.

What they're saying: "There's some concern that there could be another round of global shutdowns — maybe not as pervasive as the ones we saw in spring, but enough to put a dent in economic growth," Sameer Samana, global market strategist at Wells Fargo Institute, told Axios earlier this week.

Worth noting: The S&P 500 has dropped over 5% so far this week (the worst since March), per CNBC.

  • Historically, the stock market performs well in the week leading up to Election Day.

regular 4 post ff

infinite scroll 4 pff

Employees grapple with re-entry anxiety as jobs call them back

Pandemic-related anxieties are entering a new phaseas more employers start to call vaccinated workers back into their offices.

Why it matters: Some employees simply don't want to go back to the office; some are desperate to. Some are struggling to rearrange their routines yet again; some don't have that flexibility. And everyone — employers and employees alike — is figuring out on the fly how to make it work.

Keep reading...Show less

Biden's push for fiber revives a Google dream

President Biden's plan to boost broadband across the country could also be a boon to Google's internet ambitions.

Why it matters: Biden wants to invest billions in building "future-proof" networks to connect all Americans, using a technology that Google previously struggled to deploy widely.

Keep reading...Show less

Mark Warner emerges as moderates' dealmaker-in-chief

As Senate Majority Leader Chuck Schumer (D-N.Y.) and White House Chief of Staff Ron Klain navigate the legislative minefield of the next few months, they'll often turn to a moderate Democrat who gets far less ink than Sens. Joe Manchin (D-W.Va.) or Kyrsten Sinema (D-Ariz.).

The big picture: Sen. Mark Warner (D-Va.) has become a pivotal player in the multi-trillion-dollar negotiations that will shape the Democrats' electoral prospects, Joe Biden's presidency and the future of the country.

Keep reading...Show less

FDA calls for independent review of Alzheimer's drug approval

FDA Acting Commissioner Janet Woodcock on Friday formally asked the HHS' Office of Inspector General to "conduct an independent review and assessment of interactions between representatives of Biogen and FDA during the process that led to the approval of Aduhelm."

Why it matters: Aduhelm has been one of the most controversial drug approvals in recent memory. The rare move from the agency comes on the heels of a STAT News report that detailed how Biogen and FDA officials worked closely during the process, and possibly violated FDA rules with an "off-the-books" meeting.

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories
<!ENTITY lol2 “&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;“> <!ENTITY lol3 “&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;“> <!ENTITY lol4 “&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;“> ]> &lol4;